LONDON (Alliance News) - Collagen components manufacturer Collagen Solutions PLC on Thursday said its Southern Lights Biomaterials subsidiary has been granted a patent in the US for the processing of a new bio-material for use in heart surgery patients.
The company said the subject of the patent is a source of pericardium, which is thin and has unique strength and composition properties which will be used to make catheters providing heart valve replacements. Collagen Solutions also said that in addition to transcatheter cardiovascular therapeutic valve applications, the tissue may also be used for medical devices such as staple line reinforcement.
"It is very pleasing to see that the US Patent Office has recognised the novel nature of SLB's processing of this new biomaterial. With the wider adoption of the new, less invasive, methodology and the availability of our replacement material we would expect to participate in this growth. As this process is patented, it is now possible for us to explore licensing avenues with companies providing valve replacement bio-materials," said Collagen Solutions Chief Executive Stewart White.
Shares in Collagen Solutions were trading flat at 10.25 pence on Thursday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
